Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made that effectively block a specific enzyme related to androgen conditions.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

New compounds may soon be tested to treat excessive hair growth in women.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.

Dutasteride improved both hair loss and acne in two young men.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.